EN
CN
  • China GMP certification for hard capsules and tablets is currently actively preparing to meet the EU GMP certification, representing the leading level of the Chinese pharmaceutical industry to be first in line with international standards.

  • A major project of the Chinese Armed Forces finally concluded a cooperation agreement with the China National Institute for Food and Drug Control, marking that the new drug project has entered a substantive preclinical stage of research.

  • Our project “Preclinical Research on a Recombinant Fusion Protein Drug that Promotes Platelet Production Activity” has been approved by the Department of Science and Technology of Guangdong Province and the Technology Innovation Fund for Science and Technology Small and Medium-sized Enterprises of Dongguan Science and Technology Bureau.

  • The company's project "Dongguan Life and Health Industry Service Innovation Base Construction" was approved by the Guangdong Provincial Department of Science and Technology for the specialization of industrial technology research and development, accelerating the modern industrial system of Songshan Lake and promoting the gathering of high-tech service companies.

  • The project "Guangdong Provincial Medical Products Biosafety Evaluation Technology Service Platform" was approved by the Guangdong Provincial Department of Science and Technology for the development and guidance of the High-tech Zone, effectively promoting the high-tech zones to enhance their industrial competitiveness and independent innovation capabilities.

  • The company cooperated with the “Preclinical Research on Targeting RPT-GH Fusion Protein Targeted with Ascending Platelet Gene Engineering” developed by the Third Military Medical University of the People's Liberation Army and obtained the approval of the major science and technology project of the Guangdong Provincial Department of Science and Technology for inclusion in the Dongguan City Government. One of the "Triple Constructions".

  • The company cooperated with the “Preclinical Research on Targeting RPT-GH Fusion Protein Targeted with Ascending Platelet Gene Engineering” developed by the Third Military Medical University of the People's Liberation Army and obtained the approval of the major science and technology project of the Guangdong Provincial Department of Science and Technology for inclusion in the Dongguan City Government. One of the "Triple Constructions"....

© Copyright 2017 Dongguan Jinmeiji Pharmaceutical Co., Ltd All Rights Reserved.
Public number two-dimensional code
客服代码A 客服代码B